National Cancer Institute

31 Center Drive, Bethesda, Maryland 20814

The National Cancer Institute is not just a medical facility but also a useful resource for other hospitals and cancer centers in the United States. Groundbreaking and translational research takes place at the National Cancer Institute that could lead to new treatment options for mesothelioma.

National Cancer Institute
Speciality Icon

Pleural Mesothelioma and Peritoneal Mesothelioma

Location icon

National Cancer Institute

31 Center Drive

Bethesda, Maryland

Dr. Raffit Hassan


jump to icon


More About Mesothelioma Treatment at the National Cancer Institute

The National Cancer Institute (NCI) is the United States federal government’s agency of cancer research and training. The NCI was established in 1937 as part of the National Institutes of Health, which is part of the Department of Health and Human Services. The National Institutes of Health Clinical Center is the largest hospital devoted 100% to medical research.

NCI’s primary mission is to conduct cancer research initiatives across different malignancies, including mesothelioma. This spearheading of cancer research is collectively called the National Cancer Program, which is the largest funding platform for cancer research in the entire world. The data reaches cancer centers and doctors throughout the country to improve the clinical trials and studies conducted at different institutions.

Dr. Raffitt Hassan is the Senior Investigator of Thoracic and Gastrointestinal Malignancies. He is in charge of all cancer research related to mesothelioma. The two types of mesothelioma are pleural mesothelioma and peritoneal mesothelioma:

  • Pleural mesothelioma is a thoracic cancer
  • Peritoneal mesothelioma is a gastrointestinal cancer
Cancer Center Specialists Icon

Experienced Mesothelioma Specialists

    • Dr. Raffitt Hassan, Chief of Thoracic and Gastrointestinal Malignancies
    • Dr. Chuong D. Hoang, investigator
Cancer Center Affiliations Icon


    • National Institutes of Health
    • Department of Health and Human Services
Cancer Center Treatments Icon

Treatment Specialties

    • Clinical trials and research
Get Connected to the National Cancer Institute - Form Image

Get Connected to the National Cancer Institute

The National Cancer Institute (NCI) is the only government-funded hospital dedicated solely to clinical research for cancer. Mesothelioma is one cancer their research focuses on – mostly through clinical trials and testing. National Cancer Institute is a leading center for conducting clinical trials for this rare disease.

Why Choose NCI?

  • Affiliation with and funding from the National Institutes of Health
  • Ongoing clinical trials at the cancer center
  • Collaboration with other cancer centers in the United States

We value your privacy and will never sell or rent your personal information to any third party.

Collaboration With Other Cancer Hospitals

NCI designates other cancer centers around the country for their treatment, patient care, and patient comfort. This designation is a badge of honor for cancer hospitals and proof of their high-quality medical care.

The mesothelioma hospitals – or hospitals featuring at least one mesothelioma specialist – with an NCI designation as a leading center are:

Database of Mesothelioma Clinical Trials

If you’re looking to enroll in a clinical trial for mesothelioma, the National Cancer Institute is the place to start your search. NCI takes part in more than a dozen studies involving mesothelioma, some dedicated just to this disease. A few examples are immunotherapy trials, photodynamic therapy studies, and even a peritoneal mesothelioma trial using immunotherapy.

Linda P., who died in 2020 of mesothelioma, was able to extend her survival  thanks to a clinical trial at NCI. She received immunotherapy plus an anti-mesothelin drug LMB-100. Her family credit the doctors and nurses at NCI for slowing the growth of tumors and giving Linda more time to spend with her family.

“She never had any more pain up until the day she died,” Laurie, her daughter, told Mesothelioma Guide. “The people at (NCI) were miracle-workers. We just loved everyone there.”

Linda’s story is an example of the power of the National Cancer Institute’s work for cancer patients, particularly those with rare diseases like mesothelioma.

Get Connected to NCI

Please reach out to our patient advocate team for help visiting the National Cancer Institute. Karen Ritter, our lead patient advocate, is a registered nurse and cancer survivor. She communicates with patients and their families about their options for treatment along with tips for going through the therapeutic process.

Email Nurse Karen at karen@mesotheliomaguide.com for help. She’d be happy to assist you in contacting NCI or giving you a list of the recruiting clinical trials happening right now.

Sources & Author

  1. National Cancer Institutes. National Institute of Health. Retrieved from: https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-cancer-institute-nci. Accessed: 03/09/2022.
  2. Mesothelioma. National Cancer Institute. Retrieved from: https://ccr.cancer.gov/staff-directory/principal-investigators/disease-focuses/mesothelioma. Accessed: 05/17/2023.
  3. Find a Cancer Center. National Cancer Institute. Retrieved from: https://www.cancer.gov/research/infrastructure/cancer-centers/find. Accessed: 03/09/2022.
  4. Raffit Hassan, M.D. National Cancer Institute. Retrieved from: https://ccr.cancer.gov/staff-directory/raffit-hassan. Accessed: 05/17/2023.
Karen image

About the Writer, Karen Ritter, RN BSN

Karen Ritter, a registered nurse, is the lead patient advocate for Mesothelioma Guide. She has a deep passion for patient care, which includes helping patients and their families search for treatment options at the top mesothelioma cancer centers. She finds the balance between encouraging patients to receive the best treatment possible while enjoying their time with loved ones and friends. Karen is a valuable asset for patients due to her knowledge of mesothelioma, compassion for the victims of this disease and dedication to guiding patients through their treatment journey.